8 news items
Dosing Continues in Lexaria's Second GLP-1 Human Pilot Study
LEXX
5 Jun 24
to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information
Lexaria Awards Contract For Third GLP-1 Human Pilot Study
LEXX
23 May 24
as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites
Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
LEXX
21 May 24
-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party
Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study
LEXX
17 May 24
as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
LEXX
8 May 24
and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility
odw6co9lacz4mwjp6pd7yqomsslaa6u2l5qsztehheat7d4iswtcf7v9bn
LEXX
6 May 24
provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness
gqlncvrvuv4qx8021uyseelstdylfxpp
LEXX
16 Apr 24
and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any
vl9tfrrt6l3ioo8xga6ww71qv7vgr1e188t1ib9843wjayr55n1xb1
LEXX
2 Apr 24
to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any
- Prev
- 1
- Next